Bayesian Capital Management, LP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 446 filers reported holding NOVAVAX INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$603,092
+188.9%
83,300
+196.4%
0.07%
+213.6%
Q2 2023$208,783
-73.6%
28,100
+82.8%
0.02%
-85.0%
Q2 2022$791,000
-63.4%
15,374
-47.7%
0.15%
-54.5%
Q1 2022$2,164,000
+115.3%
29,383
+506.3%
0.32%
+11.0%
Q3 2021$1,005,000
-30.8%
4,846
-63.8%
0.29%
-18.0%
Q3 2020$1,452,00013,4000.36%
Other shareholders
NOVAVAX INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 2,559,918$543,496,0008.72%
Foresite Capital Management I, LLC 66,810$14,184,0008.55%
Samsara BioCapital, LLC 198,600$42,165,0005.20%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 330,541$70,177,0004.54%
Foresite Capital Management II, LLC 67,373$14,304,0003.85%
Rock Springs Capital Management LP 455,000$96,601,0001.91%
DELTEC ASSET MANAGEMENT LLC 56,320$11,957,0001.65%
Parametrica Management Ltd 10,200$2,166,0001.60%
SECTORAL ASSET MANAGEMENT INC 88,450$18,779,0001.52%
TSP Capital Management Group, LLC 18,525$3,933,0001.29%
View complete list of NOVAVAX INC shareholders